Point: the Power of Data to (mis)guide Policy to Improve Cancer Health Equity.

Melissa A. Simon,Laura S. Tom,XinQi Dong

DOI: https://doi.org/10.6004/jnccn.2016.0110

IF: 12.6934

2016-01-01

Journal of the National Comprehensive Cancer Network

Abstract:Health expenditures have been an ongoing topic of debate in many health policy spheres. This issue of JNCCN includes an article, “Wealth, Health Expenditure, and Cancer: A National Perspective” (see page 972), that aims to provide a national perspective on the complicated interplay of wealth, health expenditures, and their relationship to cancer screening. In this ecological study, the investigators calculated Spearman’s rank correlations to determine the association between financial indicators (gross domestic product [GDP] and health expenditure per capita) and cancer outcomes at the state level. The study found that only breast cancer mortality/ incidence ratios were significantly correlated with health expenditure; all-cancer and colorectal cancer (CRC) outcomes were not. The investigators suggest that “findings represent evidence of regional disparities in terms of financial and cancer outcomes, indicating a potential inefficient allocation of resources in the efforts against cancer.” We, as scientists, have the opportunity to move the needle on cancer health equity. Some may argue that within this opportunity lies an underlying social responsibility to consider how science affects public conversations and policy decisions that shape our present and future society. The messages we send to consumers in our publications are scrutinized not only by the readers of scientific journals but also by the wider media. Media then frame the messages and subsequently distill them to policymakers, other leaders, and, most importantly, communities, including those who are differentially impacted by these messages. Our concern with this article is that in the absence of additional angles and levels of analyses, these ecological data provide a limited viewpoint that does little to advance the groundwork necessary for future policy development and policy implementation. We caution the readers in interpreting these data out of context. This article presents data that predate the Affordable Care Act (ACA) implementation and the financial downturn experienced in the United States in 2008 and 2009. Studies have yet to fully illuminate the impact of the downturn and recovery from it and ACA implementation. The state-level data included in the study are also focused on broad health expenditures and not those specific to cancer. Variation within a state, especially among rural, suburban, and urban contexts and populations, are absent. Although conducting analyses at a more micro-level, such as county or city, would generate valuable findings, we understand this was outside the scope of this article’s intent. Therefore, as a whole, these data may not be indicative of the “here and now,” and we caution readers eager to use this study to extrapolate to the local level or to cancer-related health expenditures. Concrete illustrations of how this study’s findings may fall short of depicting the interplay of wealth and expenditures as it impacts cancer outcomes can be found in cities where local data contrast with state trends. For example, Chicago has a significant black:white mortality disparity in breast cancer. Where one lives does impact health, and in Chicago’s 77 community areas, there are major wealth and health expenditure differences in resource allocation at a community area level that can drive poor cancer outcomes. This picture might not be clear from reading the article. Melissa A. Simon, MD, MPH